FDA Provides Update on Abortion Drug Review 

Last week, the Food and Drug Administration (FDA) provided a court-ordered update on the status of the agency’s long-awaited safety review of the abortion drug mifepristone. The study officially began in September 2025 with a completion date set for the end of 2026—but on October 7, the agency reported that the study would be published […]